Research Abstract
[Transient liver damage due to prajmalium bitartrate].
AI Summary
Key Findings
0:00 / 0:00
0:00 / 0:00
Abstract
3 patients developed transient cholestatic jaundice after administration of prajmalium bitartrate, a class I antiarrhythmic drug. The leukocyte inhibition tests showed 4%, 12% and 15% inhibition, respectively, while eosinophilia was seen in all 3, supporting the assumption that the transient hepatic damage was due to drug exposure. Discontinuing the drug resulted in improvement in the clinical and biochemical findings.
Affiliation
Medical Dept. A, Rambam Medical Center, Haifa.
External References
- PubMed ID:
- 2010122
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.